Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (CrossMab) (CROSSAB-001)

Recombinant Anti-B cell lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget immune cells to tumor cells. It is designed for the research of B cell lymphoma therapy.

Datasheet INQUIRY

Specifications

Targets

B Cell Lymphoma BCL1 Idiotype & CD64

Type

CrossMab

Species Reactivity

Mouse

Application

FuncS; Promising therapeutic agent

Related Disease

B cell lymphoma

Targets

Target 1

B Cell Lymphoma BCL1 Idiotype

Alternative Names

B cell lymphoma BCL1 Idiotype; B cell lymphoma; BCL1; Idiotype; Id; 31D1; 32D1

Target 2

CD64

Gene ID

14129

UniProt ID

P26151

Alternative Names

FcγRI; FCGR1A; Fc fragment of IgG, high affinity Ia, receptor (CD64); CD64; FCRI; CD64A; IGFR1; high affinity immunoglobulin gamma Fc receptor I; fcgammaRIa; Fc-gamma RI; fc-gamma RIA; Fc gamma receptor; IgG Fc receptor I; Fc-gamma receptor I A1; Fc fragment of IgG, high affinity Ia, receptor for (CD64); FCGR1B, FCGR1C

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "B Cell Lymphoma BCL1 Idiotype & CD64"

See other bsAb targets related to "B Cell Lymphoma BCL1 Idiotype"

See other bsAb targets related to "CD64"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (CrossMab) (CROSSAB-001). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (CrossMab) (CAT#: CROSSAB-001)

Specifications

Targets

Customer Reviews and Q&As